We therefore suggest that if EGFR is overexpressed, its activation can be increased by NEU3, but if EGFR is in a normal status, as in the normal intestinal mucosa, NEU3 activity is not able to transform EGFR into a cancer driver. The gene discussed is NEU3; the disease is cancer.